• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.66% Nasdaq Down1.05%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NGM
    9.88 Down 0.32(3.14%) Sep 4, 4:00PM EDT
    |After Hours : 9.88 Down 0.00 (0.01%) Sep 4, 4:44PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Net Income (22,779) (34,759) (9,696) (27,901)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,038  1,054  412  570  
    Adjustments To Net Income7,068  5,307  6,232  4,976  
    Changes In Accounts Receivables2,646  (935)(1,975)5,314  
    Changes In Liabilities(11,455)(7,573)(28,613)79,645  
    Changes In Inventories -   -   -   -  
    Changes In Other Operating Activities(973)1,500  1,736  (1,370)
    Total Cash Flow From Operating Activities (24,578) (35,079) (31,685) 61,097  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(2,901)(1,204)(1,321)(1,731)
    Investments28,800  25,163  (35,773)(38,834)
    Other Cash flows from Investing Activities -   -  (2) -  
    Total Cash Flows From Investing Activities 25,899   23,959   (37,096) (40,565)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  (7)
    Sale Purchase of Stock3,510  4,265  3,803  1,645  
    Net Borrowings -   -  344  400  
    Other Cash Flows from Financing Activities -   -  (1)2  
    Total Cash Flows From Financing Activities 3,510   4,265   4,146   2,040  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents 4,831   (6,855) (64,635) 22,572  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.